h-TREK1 polypeptides and h-TREK1 polynucleotides

Details h-TREK1 polypeptides and h-TREK1 polynucleotides h-TREK1 polypeptides and h-TREK1 polynucleotides

1999-01-25

2001-06-05

Clark, Deborah J. R. (Department: 1633)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S320100, C435S325000, C435S440000, C435S455000, C536S023100, C536S023500

Reexamination Certificate

active

06242217

ABSTRACT:

FIELD OF THE INVENTION
This invention relates to newly identified polypeptides and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be agonists, antagonists and /or inhibitors which are potentially useful in therapy, and to production of such polypeptides and polynucleotides.
BACKGROUND OF THE INVENTION
The drug discovery process is currently undergoing a fundamental revolution as it embraces ‘functional genomics’, that is, high throughput genome- or gene-based biology. This approaches a means to identify genes and gene products as therapeutic targets is rapidly superseding earlier approaches based on ‘positional cloning’. A phenotype, that is a biological function or genetic disease, would be identified and this would then be tracked back to the responsible gene, based on its genetic map position.
Functional genomics relies heavily on high-throughput DNA sequencing technologies and the various tools of bioinformatics to identify gene sequences of potential interest from the many molecular biology databases now available. There is a continuing need to identify and characterise further genes and their related polypeptides/proteins, as targets for drug discovery.
SUMMARY OF THE INVENTION
The present invention relates to h-TREK1, in particular h-TREK1 polypeptides and h-TREK1 polynucleotides, recombinant materials and methods for their production. In another aspect, the invention relates to methods for using such polypeptides and polynucleotides, including the treatment of cancer, pulmonary disease, cardiovascular diseases, inflammatory diseases, renal disease, pain, psychiatric disorders including depression and schizophrenia, neurodegenerative disease including Alzheimer's, stroke and head trauma and neurological disorders including migraine, hereinafter referred to as “the Diseases”, amongst others In a further aspect, the invention relates to methods for identifying agonists and antagonists/inhibitors using the materials provided by the invention, and treating conditions associated with h-TREK1 imbalance with the identified compounds In a still further aspect, the invention relates to diagnostic assays for detecting diseases associated with inappropriate h-TREK1 activity or levels.


REFERENCES:
H.J. Meadows et al., “Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel”,Pflügers Arch Eur J. Physiol, vol. 439, pp. 714-722 (2000).
Lesage et al., “Potassium Channels with Two P Domains”,Molecular Structure Function and Diseases, vol. 46, pp. 199-222 (1999).
Hans Meves, “Modulation of Ion Channels by Arachidonic Acid”,Progress in Neurobiology, vol. 43, pp. 175-186 (1994).
Fink et al. “Cloning, functional expression and brain localization of a novel unconventional outward Rectifier K+channel”, The EMBO Journal, vol. 15 (24), pp. 6854-6862 (1996).
Patel et al. “A mammalian two pore domain mechano-gated S-like K+channel”, The EMBO Journal, vol. 17 (15), pp. 4283-4290 (1998).
GenBank Accession #AA464375.
GenBank Accession #U73488.
Fink et al. EMBO J. 15(24): 6854-6862, 1996.*
Lesage et al. EMBO J. 15(5): 1004-1011, 1996.*
Reyes et al. J. of Biological Chemistry. 273(47):30863-9, Nov. 1998.*
Bringmann et al. Neuroscience. 86(4): 1291-306, Oct. 1998.*
Leube et al. Journal of Cell Biology. 127(6):1589-1601, Dec. 1994.*
Branch, AD. TIBS 23: 45-50, Feb. 1998.*
Verma et al. Nature. 389: 239-242, Sep. 1997.*
Ledley, FD. Pharmaceutical Research. 13: 1595-1613, Nov. 1996.*
Fink et al. GenCore Accession No. MU73488, Jan. 1997.*
Hillier et al. GenCore Accession No. A464375, Jun. 1997.

Affiliated with

Also associated with

Rating

h-TREK1 polypeptides and h-TREK1 polynucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with h-TREK1 polypeptides and h-TREK1 polynucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and h-TREK1 polypeptides and h-TREK1 polynucleotides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2501439